NCT03980093View on ClinicalTrials.gov

The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Breast Cancer
Interventions
BEHAVIORAL

Education

Online medical education on the benefits of anti-hormonal medication, potential side effects, and how to manage them.

BEHAVIORAL

Values

An Acceptance and Commitment Therapy (ACT)-based intervention consisting of brief online sessions plus a visual cue-based intervention focused on personal values.

Trial Locations (1)

80111

Rocky Mountain Cancer Centers, Greenwood Village

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Colorado, Boulder

OTHER

NCT03980093 - The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors | Biotech Hunter | Biotech Hunter